NEW YORK, May 26, 2011 /PRNewswire/ — Aeolus Pharmaceuticals,
Inc. (OTCQB: AOLS) today announced that John McManus, the
company’s Chief Executive Officer, will presenting at
RetailInvestorConferences.com. DATE:

June 2nd, 2011TIME:

2:00 PM EDTLINK:

www.retailinvestorconferences.com
> Click the red “register/ watch event now” button.This will be
a live, interactive online event where investors are invited to ask
the company questions in real-time both in the presentation hall as
well as the company’s “virtual trade booth.” If attendees are not
able to join the event live in real-time, an on-demand archive will
be available for 90 days.

It is recommended that investors
pre-register to save time and receive event updates.

About Aeolus PharmaceuticalsAeolus Pharmaceuticals is
developing a new class of catalytic antioxidant compounds that
protects healthy tissue from the damaging effects of radiation. Its
first compound, AEOL 10150, is being developed for oncology
indications, where it is used in combination with radiation
therapy. It is also being developed, with up to $140 million in
funding by the US Government, as a medical countermeasure against
chemical and radiological weapons, where its initial target
indications are as a protective agent against the effects of acute
radiation syndrome and delayed effects of acute radiation exposure.
Aeolus’ strategy is to leverage the
substantial investment in toxicology, manufacturing, and
preclinical and clinical studies made by US Government agencies in
AEOL 10150 to efficiently develop the compound for use in
oncology.

About
RetailInvestorConferences.com:RetailInvestorConferences.com,
created by BetterInvesting
(NAIC

‘/>”/>

SOURCE